ALPHAGAN P

Product NDC: 0023-9321
11-digit product format: 000239321
Labeler code: 0023
Product ID: 0023-9321_f1dec1d6-7362-407f-abe3-c119c55832ef
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: brimonidine tartrate
Dosage form: SOLUTION/ DROPS
Route: OPHTHALMIC
Labeler: Allergan, Inc.
Application: NDA021770
Marketing category: NDA
Marketing start: 2006-01-25
Substance: BRIMONIDINE TARTRATE
Active strength: 1 mg/mL
Pharmacologic classes: Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021770-001	ALPHAGAN P	BRIMONIDINE TARTRATE	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N021770-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD, RS	2005-08-19	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD, RS	2005-08-19	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD, RS	2005-08-19	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD, RS	2005-08-19	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD, RS	2005-08-19	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD, RS	2005-08-19	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD, RS	2005-08-19	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD, RS	2005-08-19	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD, RS	2005-08-19	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD, RS	2005-08-19	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD, RS	2005-08-19	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD, RS	2005-08-19	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD, RS	2005-08-19	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC	AB	RLD, RS	2005-08-19	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD, RS	2005-08-19	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD, RS	2005-08-19	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N021770-001	ALPHAGAN P	0.1%	SOLUTION/DROPS / OPHTHALMIC		RLD, RS	2005-08-19	`e64feba35796…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	N021770-001	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N021770-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021770-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021770-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021770-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021770-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021770-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021770-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021770-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021770-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021770-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021770-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021770-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021770-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021770-001	AB	1	`8072bd15b7f6…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N021770-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N021770-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N021770-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N021770-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N021770-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N021770-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N021770-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N021770-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N021770-001	AB	1	`3bdfa0b2c4d7…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N021770-001	AB	1	`a50c72e98297…`

Observed Orange Book patent history#

Patent history page 1 of 6 · 230 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021770-001	8858961*PED	2024-03-02		Pediatric extension		`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021770-001	8858961*PED	2024-03-02		Pediatric extension		`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021770-001	8858961*PED	2024-03-02		Pediatric extension		`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021770-001	8858961*PED	2024-03-02		Pediatric extension		`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021770-001	8858961*PED	2024-03-02		Pediatric extension		`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021770-001	8858961*PED	2024-03-02		Pediatric extension		`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021770-001	8858961*PED	2024-03-02		Pediatric extension		`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021770-001	8858961*PED	2024-03-02		Pediatric extension		`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021770-001	8858961*PED	2024-03-02		Pediatric extension		`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021770-001	6562873*PED	2022-01-10		Pediatric extension		`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021770-001	9295641*PED	2022-01-10		Pediatric extension		`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021770-001	9687443*PED	2022-01-10		Pediatric extension		`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021770-001	6627210*PED	2022-01-18		Pediatric extension		`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021770-001	6673337*PED	2022-01-26		Pediatric extension		`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021770-001	6641834*PED	2022-01-28		Pediatric extension		`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021770-001	8858961	2023-09-02		Drug product	2014-11-13	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021770-001	8858961*PED	2024-03-02		Pediatric extension		`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021770-001	6562873*PED	2022-01-10		Pediatric extension		`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021770-001	9295641*PED	2022-01-10		Pediatric extension		`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021770-001	9687443*PED	2022-01-10		Pediatric extension		`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021770-001	6627210*PED	2022-01-18		Pediatric extension		`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021770-001	6673337*PED	2022-01-26		Pediatric extension		`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021770-001	6641834*PED	2022-01-28		Pediatric extension		`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021770-001	8858961	2023-09-02		Drug product	2014-11-13	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021770-001	8858961*PED	2024-03-02		Pediatric extension		`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021770-001	6562873*PED	2022-01-10		Pediatric extension		`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021770-001	9295641*PED	2022-01-10		Pediatric extension		`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021770-001	9687443*PED	2022-01-10		Pediatric extension		`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021770-001	6627210*PED	2022-01-18		Pediatric extension		`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021770-001	6673337*PED	2022-01-26		Pediatric extension		`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021770-001	6641834*PED	2022-01-28		Pediatric extension		`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021770-001	8858961	2023-09-02		Drug product	2014-11-13	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021770-001	8858961*PED	2024-03-02		Pediatric extension		`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021770-001	10307368	2021-07-10		Drug product	2019-06-24	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021770-001	6562873	2021-07-10		Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021770-001	9295641	2021-07-10	U-1833		2016-04-28	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021770-001	9687443	2021-07-10		Drug product	2017-07-10	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021770-001	6627210	2021-07-18		Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021770-001	6673337	2021-07-26		Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021770-001	6641834	2021-07-28		Drug product		`74a2ff9319b5…`

Additional Listing Data#

Finished product: Yes
Brand name base: ALPHAGAN P
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
BRIMONIDINE TARTRATE	1 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
4S9CL2DY2H	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
861204	Internal RxNorm lookup
861206	Internal RxNorm lookup
861208	Internal RxNorm lookup
861210	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
264c4494-c225-486f-888a-caaf36be46b3	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
9e37788c-b1bf-42ae-aac9-b60601606144	Product name	8	20260122
c6c0c444-a6ba-2fb5-a7bc-7f0443fa5791	Product name	4	20251208
8ec6541e-9842-115f-62bf-f7c9ab3aeddb	Product name	3	20250805
30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2	Product name	5	20250304
1527ac37-808d-43be-a63e-74e1258dbe46	Product name	9	20250219
39b7fcf4-8865-6d40-d24d-9b8c28bd6345	Product name	5	20250123
bed0530e-f939-4541-956b-6928a2f6404f	Product name	1	20241008
cefa60e2-a5b5-493e-9c54-24735b7dc509	Product name	6	20240814
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
9fcb7a91-de07-4f00-aabf-e4d6fda403d5	Product name	8	20230322
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
c93ffd9a-5bad-44d8-b5e5-16ef4d2fee72	Product name	1	20220316
9badc7be-250a-44ab-aa36-926af3f02679	Product name	1	20210527
0ec3537a-6c9b-432a-896c-b9ea8723049a	Product name	9	20200701
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
7916de40-e296-41f0-b811-6d0df1a33e2c	Product name	9	20180627
cefa60e2-a5b5-493e-9c54-24735b7dc509	Product name	2	20171212
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
5668b646-cd56-c3c7-bdea-3f6b1a8840db	Product name	1	20140508
810ab97e-f109-f41c-7c83-6a652a9cbf43	Product name	1	20140508
87711080-88eb-65c5-b2dd-bf99e700a372	Product name	1	20140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2dd	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0023-9321-03	ALPHAGAN P	1 in 1 CARTON	SOLUTION/ DROPS	1	24
0023-9321-03	ALPHAGAN P	3 mL in 1 BOTTLE, DROPPER	SOLUTION/ DROPS	3	24
0023-9321-05	ALPHAGAN P	1 in 1 CARTON	SOLUTION/ DROPS	1	24
0023-9321-05	ALPHAGAN P	5 mL in 1 BOTTLE, DROPPER	SOLUTION/ DROPS	5	24
0023-9321-10	ALPHAGAN P	1 in 1 CARTON	SOLUTION/ DROPS	1	24
0023-9321-10	ALPHAGAN P	10 mL in 1 BOTTLE, DROPPER	SOLUTION/ DROPS	10	24
0023-9321-15	ALPHAGAN P	15 mL in 1 BOTTLE, DROPPER	SOLUTION/ DROPS	15	24
0023-9321-15	ALPHAGAN P	1 in 1 CARTON	SOLUTION/ DROPS	1	24

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0023-9321-05	ML - Milliliter	0023-9321	5f93815f-ebe6-44fb-8462-b0274116eb9c	1	2012-07-24
0023-9321-10	ML - Milliliter	0023-9321	fd89ebce-6142-472f-9785-ea377bb592e6	1	2012-07-24
0023-9321-15	ML - Milliliter	0023-9321	9c1b17d8-4702-408f-9f16-cf1859770e1c	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
brimonidine tartrate	ACTIVE INGREDIENT	4S9CL2DY2H	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [ALLERGAN, INC. ]	10
brimonidine	ACTIVE MOIETY	E6GNX3HHTE	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [ALLERGAN, INC. ]	10
boric acid	INACTIVE INGREDIENT	R57ZHV85D4	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [ALLERGAN, INC. ]	10
calcium chloride	INACTIVE INGREDIENT	M4I0D6VV5M	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [ALLERGAN, INC. ]	10
carboxymethylcellulose sodium	INACTIVE INGREDIENT	K679OBS311	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [ALLERGAN, INC. ]	10
hydrochloric acid	INACTIVE INGREDIENT	QTT17582CB	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [ALLERGAN, INC. ]	10
magnesium chloride	INACTIVE INGREDIENT	02F3473H9O	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [ALLERGAN, INC. ]	10
potassium chloride	INACTIVE INGREDIENT	660YQ98I10	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [ALLERGAN, INC. ]	10
sodium borate	INACTIVE INGREDIENT	91MBZ8H3QO	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [ALLERGAN, INC. ]	10
sodium chloride	INACTIVE INGREDIENT	451W47IQ8X	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [ALLERGAN, INC. ]	10
sodium hydroxide	INACTIVE INGREDIENT	55X04QC32I	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [ALLERGAN, INC. ]	10
water	INACTIVE INGREDIENT	059QF0KO0R	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [ALLERGAN, INC. ]	10
brimonidine tartrate	ACTIVE INGREDIENT	4S9CL2DY2H	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [PHYSICIANS TOTAL CARE, INC.]	4
brimonidine	ACTIVE MOIETY	E6GNX3HHTE	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [PHYSICIANS TOTAL CARE, INC.]	4
boric acid	INACTIVE INGREDIENT	R57ZHV85D4	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [PHYSICIANS TOTAL CARE, INC.]	4
calcium chloride	INACTIVE INGREDIENT	M4I0D6VV5M	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [PHYSICIANS TOTAL CARE, INC.]	4
carboxymethylcellulose sodium	INACTIVE INGREDIENT	K679OBS311	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [PHYSICIANS TOTAL CARE, INC.]	4
hydrochloric acid	INACTIVE INGREDIENT	QTT17582CB	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [PHYSICIANS TOTAL CARE, INC.]	4
magnesium chloride	INACTIVE INGREDIENT	02F3473H9O	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [PHYSICIANS TOTAL CARE, INC.]	4
potassium chloride	INACTIVE INGREDIENT	660YQ98I10	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [PHYSICIANS TOTAL CARE, INC.]	4
sodium borate	INACTIVE INGREDIENT	91MBZ8H3QO	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [PHYSICIANS TOTAL CARE, INC.]	4
sodium chloride	INACTIVE INGREDIENT	451W47IQ8X	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [PHYSICIANS TOTAL CARE, INC.]	4
sodium hydroxide	INACTIVE INGREDIENT	55X04QC32I	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [PHYSICIANS TOTAL CARE, INC.]	4
water	INACTIVE INGREDIENT	059QF0KO0R	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [PHYSICIANS TOTAL CARE, INC.]	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0023-9321	ALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [ALLERGAN, INC.]	23	Current NDC, Legacy NDC, 8 package rows	20250424_264c4494-c225-486f-888a-caaf36be46b3.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Brimonidine tartrate	BRIMONIDINE TARTRATE	Pacific Pharma, Inc.	5c4aea88-95ca-4da8-a3da-02f10c8b6623	2025-09-18	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021770 application number: NDA021770
ALPHAGAN P	BRIMONIDINE TARTRATE	Allergan, Inc.	264c4494-c225-486f-888a-caaf36be46b3	2025-09-18	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021770 application number: NDA021770 ndc (product): 0023-9321

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
4S9CL2DY2H	BRIMONIDINE TARTRATE	70359-46-5	BRIMONIDINE TARTRATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
861206	Alphagan P 0.1 % Ophthalmic Solution	PSN	264c4494-c225-486f-888a-caaf36be46b3	24
861210	Alphagan P 0.15 % Ophthalmic Solution	PSN	264c4494-c225-486f-888a-caaf36be46b3	24
861204	brimonidine tartrate 0.1 % Ophthalmic Solution	PSN	264c4494-c225-486f-888a-caaf36be46b3	24
861208	brimonidine tartrate 0.15 % Ophthalmic Solution	PSN	264c4494-c225-486f-888a-caaf36be46b3	24
861206	brimonidine tartrate 1 MG/ML Ophthalmic Solution [Alphagan]	SBD	264c4494-c225-486f-888a-caaf36be46b3	24
861210	brimonidine tartrate 1.5 MG/ML Ophthalmic Solution [Alphagan]	SBD	264c4494-c225-486f-888a-caaf36be46b3	24
861204	brimonidine tartrate 1 MG/ML Ophthalmic Solution	SCD	264c4494-c225-486f-888a-caaf36be46b3	24
861208	brimonidine tartrate 1.5 MG/ML Ophthalmic Solution	SCD	264c4494-c225-486f-888a-caaf36be46b3	24
861206	Alphagan 1 MG/ML Ophthalmic Solution	SY	264c4494-c225-486f-888a-caaf36be46b3	24
861210	Alphagan 1.5 MG/ML Ophthalmic Solution	SY	264c4494-c225-486f-888a-caaf36be46b3	24
861206	Alphagan P 0.1 % Ophthalmic Drops	SY	264c4494-c225-486f-888a-caaf36be46b3	24
861210	Alphagan P 0.15 % Ophthalmic Drops	SY	264c4494-c225-486f-888a-caaf36be46b3	24
861204	brimonidine tartrate 0.1 % Ophthalmic Solution	SY	264c4494-c225-486f-888a-caaf36be46b3	24
861208	brimonidine tartrate 0.15 % Ophthalmic Drops	SY	264c4494-c225-486f-888a-caaf36be46b3	24
861206	Alphagan P 0.1 % Ophthalmic Solution	PSN	ba15fa83-c808-4298-bb0e-43ed1429c526	4
861210	Alphagan P 0.15 % Ophthalmic Solution	PSN	ba15fa83-c808-4298-bb0e-43ed1429c526	4
861204	brimonidine tartrate 0.1 % Ophthalmic Solution	PSN	ba15fa83-c808-4298-bb0e-43ed1429c526	4
861208	brimonidine tartrate 0.15 % Ophthalmic Solution	PSN	ba15fa83-c808-4298-bb0e-43ed1429c526	4
861206	brimonidine tartrate 1 MG/ML Ophthalmic Solution [Alphagan]	SBD	ba15fa83-c808-4298-bb0e-43ed1429c526	4
861210	brimonidine tartrate 1.5 MG/ML Ophthalmic Solution [Alphagan]	SBD	ba15fa83-c808-4298-bb0e-43ed1429c526	4
861204	brimonidine tartrate 1 MG/ML Ophthalmic Solution	SCD	ba15fa83-c808-4298-bb0e-43ed1429c526	4
861208	brimonidine tartrate 1.5 MG/ML Ophthalmic Solution	SCD	ba15fa83-c808-4298-bb0e-43ed1429c526	4
861206	Alphagan 1 MG/ML Ophthalmic Solution	SY	ba15fa83-c808-4298-bb0e-43ed1429c526	4
861210	Alphagan 1.5 MG/ML Ophthalmic Solution	SY	ba15fa83-c808-4298-bb0e-43ed1429c526	4
861206	Alphagan P 0.1 % Ophthalmic Drops	SY	ba15fa83-c808-4298-bb0e-43ed1429c526	4
861210	Alphagan P 0.15 % Ophthalmic Drops	SY	ba15fa83-c808-4298-bb0e-43ed1429c526	4
861204	brimonidine tartrate 0.1 % Ophthalmic Solution	SY	ba15fa83-c808-4298-bb0e-43ed1429c526	4
861208	brimonidine tartrate 0.15 % Ophthalmic Drops	SY	ba15fa83-c808-4298-bb0e-43ed1429c526	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0023-9321-03	00023932103	1 BOTTLE, DROPPER in 1 CARTON (0023-9321-03) / 3 mL in 1 BOTTLE, DROPPER	2006-01-25	0000-00-00	No	No	Current
0023-9321-05	00023932105	1 BOTTLE, DROPPER in 1 CARTON (0023-9321-05) / 5 mL in 1 BOTTLE, DROPPER	2006-01-25	0000-00-00	No	No	Current
0023-9321-10	00023932110	1 BOTTLE, DROPPER in 1 CARTON (0023-9321-10) / 10 mL in 1 BOTTLE, DROPPER	2006-01-25	0000-00-00	No	No	Current
0023-9321-15	00023932115	1 BOTTLE, DROPPER in 1 CARTON (0023-9321-15) / 15 mL in 1 BOTTLE, DROPPER	2006-01-25	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
ALPHAGAN P	Allergan, Inc.	2025-09-18	HUMAN PRESCRIPTION DRUG LABEL	25
ALPHAGAN P	Physicians Total Care, Inc.	2013-03-15	HUMAN PRESCRIPTION DRUG LABEL	4